1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Langelaan, D.N. Rainey, J.K. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J Phys Chem Lett 1948-7185 8 2381 2386 10.1021/acs.jpclett.7b00867 28492329 Preserved Transmembrane Segment Topology, Structure, and Dynamics in Disparate Micellar Environments. 2017 0000-0003-0793-5573 10.2210/pdb2low/pdb pdb_00002low 7306.109 Apelin receptor UNP residues 1-55 1 man polymer Angiotensin receptor-like 1, G-protein coupled receptor APJ, G-protein coupled receptor HG11 no no MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample APLNR, AGTRL1, APJ 9606 Homo sapiens 562 Escherichia coli pEXP5-CT Solution NMR structure of the N-terminus and first transmembrane segment of the apelin receptor solubilised in 50% HFIP/50% water database_2 pdbx_database_status pdbx_nmr_software pdbx_nmr_spectrometer struct_ref_seq_dif citation citation_author repository Initial release Database references Data collection Database references Other Database references 1 0 2013-01-16 1 1 2017-05-24 1 2 2023-06-14 1 3 2023-07-26 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details _citation.journal_volume _citation_author.identifier_ORCID BMRB Y RCSB 2012-01-27 REL REL REL REL structures with the lowest energy 100 40 2D 1H-13C HSQC/HMQC 3D HNCO HNcaCO (H[N[ca[CO]]]) 3D HNCA HNcoCACB (H[N[co[{CA|ca[C]}]]]) 3D HNCA 3D HN(CO)CA 3D 1H-15N TOCSY 3D 1H-15N NOESY 3D HCCH-TOCSY 3D 1H-13C NOESY HSQC_NOESY_125ms_HSQC (h[C]_H[N].NOESY) 15NHSQC .9 mM [U-99% 13C; U-99% 15N] 50 % [U-99% 2H] 1 mM 5 mM [U-99% 2H] 40 % 10 % [U-99% 2H] 310 K simulated annealing, torsion angle dynamics 1 extended conformation .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O 50% Hexafluoroisopropanol/40% H2O /10% D2O CCPN chemical shift assignment CcpNmr Analysis 2.2 CCPN peak picking CcpNmr Analysis 2.2 Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax processing NMRPipe Schwieters, Kuszewski, Tjandra and Clore structure solution X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore refinement X-PLOR NIH 700 Bruker AVANCE III Bruker Avance III MET 1 n 1 MET 1 A GLU 2 n 2 GLU 2 A GLU 3 n 3 GLU 3 A GLY 4 n 4 GLY 4 A GLY 5 n 5 GLY 5 A ASP 6 n 6 ASP 6 A PHE 7 n 7 PHE 7 A ASP 8 n 8 ASP 8 A ASN 9 n 9 ASN 9 A TYR 10 n 10 TYR 10 A TYR 11 n 11 TYR 11 A GLY 12 n 12 GLY 12 A ALA 13 n 13 ALA 13 A ASP 14 n 14 ASP 14 A ASN 15 n 15 ASN 15 A GLN 16 n 16 GLN 16 A SER 17 n 17 SER 17 A GLU 18 n 18 GLU 18 A CYS 19 n 19 CYS 19 A GLU 20 n 20 GLU 20 A TYR 21 n 21 TYR 21 A THR 22 n 22 THR 22 A ASP 23 n 23 ASP 23 A TRP 24 n 24 TRP 24 A LYS 25 n 25 LYS 25 A SER 26 n 26 SER 26 A SER 27 n 27 SER 27 A GLY 28 n 28 GLY 28 A ALA 29 n 29 ALA 29 A LEU 30 n 30 LEU 30 A ILE 31 n 31 ILE 31 A PRO 32 n 32 PRO 32 A ALA 33 n 33 ALA 33 A ILE 34 n 34 ILE 34 A TYR 35 n 35 TYR 35 A MET 36 n 36 MET 36 A LEU 37 n 37 LEU 37 A VAL 38 n 38 VAL 38 A PHE 39 n 39 PHE 39 A LEU 40 n 40 LEU 40 A LEU 41 n 41 LEU 41 A GLY 42 n 42 GLY 42 A THR 43 n 43 THR 43 A THR 44 n 44 THR 44 A GLY 45 n 45 GLY 45 A ASN 46 n 46 ASN 46 A GLY 47 n 47 GLY 47 A LEU 48 n 48 LEU 48 A VAL 49 n 49 VAL 49 A LEU 50 n 50 LEU 50 A TRP 51 n 51 TRP 51 A THR 52 n 52 THR 52 A VAL 53 n 53 VAL 53 A PHE 54 n 54 PHE 54 A ARG 55 n 55 ARG 55 A LYS 56 n 56 LYS 56 A LYS 57 n 57 LYS 57 A GLY 58 n 58 GLY 58 A HIS 59 n 59 HIS 59 A HIS 60 n 60 HIS 60 A HIS 61 n 61 HIS 61 A HIS 62 n 62 HIS 62 A HIS 63 n 63 HIS 63 A HIS 64 n 64 HIS 64 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A HD21 H ASN TYR 9 10 1.26 7 A A HD21 H ASN TYR 9 10 1.30 20 A A HD21 H ASN TYR 9 10 1.33 1 A ASP 6 -172.57 58.61 1 A ASN 9 45.22 -171.28 1 A TYR 10 55.53 116.52 1 A ALA 33 -56.41 -70.58 1 A LEU 40 -66.47 2.61 1 A LEU 41 -100.61 -63.22 1 A THR 44 -134.99 -50.68 1 A HIS 60 -137.45 -92.87 1 A HIS 61 -150.79 -63.67 1 A HIS 62 -168.86 114.02 2 A GLU 2 -50.58 95.85 2 A GLU 3 -57.51 -172.67 2 A ASP 6 178.16 70.86 2 A ASN 9 -41.52 -82.15 2 A TYR 10 -40.63 157.20 2 A GLU 18 -59.56 -74.85 2 A TRP 24 -38.06 -34.76 2 A LEU 40 -63.46 0.01 2 A ASN 46 -126.80 -50.62 2 A HIS 61 -102.49 -153.95 2 A HIS 62 -99.36 -70.24 2 A HIS 63 -100.79 42.71 3 A GLU 2 57.26 -175.07 3 A GLU 3 49.73 -166.39 3 A ASP 6 -170.71 54.83 3 A TYR 10 -72.62 37.24 3 A TYR 11 -162.62 39.70 3 A ASN 15 -49.83 -13.63 3 A GLU 18 -56.41 -5.65 3 A LEU 30 -137.28 -31.78 3 A LEU 40 -64.70 0.59 3 A THR 44 -136.79 -51.33 3 A VAL 49 -60.20 -72.74 3 A HIS 60 -55.99 -109.29 3 A HIS 61 -152.11 -55.67 3 A HIS 62 -156.59 -44.41 3 A HIS 63 -98.22 41.69 4 A GLU 3 -172.49 56.16 4 A ASP 6 -149.62 47.48 4 A TYR 10 -62.97 70.27 4 A ALA 13 -131.80 -31.82 4 A ALA 29 -105.16 41.51 4 A LEU 30 -174.00 -28.51 4 A LEU 37 -46.91 -17.60 4 A LEU 40 -65.95 1.45 4 A LEU 41 -101.22 -61.03 4 A THR 44 -135.94 -51.26 4 A HIS 62 77.97 -34.92 5 A GLU 3 -174.16 -167.49 5 A ASN 9 -46.17 -79.48 5 A GLU 18 -49.54 -14.09 5 A ALA 29 -144.54 -3.94 5 A LEU 30 -137.87 -34.52 5 A ALA 33 -54.12 -72.05 5 A LEU 41 -49.98 -71.14 5 A THR 43 -48.20 -13.19 5 A VAL 49 -62.15 -74.99 5 A HIS 62 -80.52 -78.93 5 A HIS 63 -93.70 41.84 6 A ASP 6 -146.69 44.93 6 A ASN 9 -54.24 176.35 6 A TYR 11 -174.20 39.93 6 A GLU 18 -58.99 -77.03 6 A SER 27 -92.52 30.34 6 A LEU 30 -147.62 -36.03 6 A THR 43 -150.96 27.11 6 A VAL 49 -59.82 -71.66 6 A PHE 54 -48.87 -12.78 6 A HIS 62 54.38 106.75 7 A ASP 6 -175.40 57.09 7 A PHE 7 62.67 134.60 7 A ASN 9 47.68 -178.02 7 A TYR 10 -49.26 88.81 7 A ASN 15 -47.69 -15.99 7 A LEU 40 -64.22 1.13 7 A LEU 41 -99.05 -65.82 7 A THR 44 -136.36 -50.87 7 A VAL 49 -60.13 -72.33 7 A HIS 62 -62.80 -92.13 7 A HIS 63 -88.70 41.24 8 A ASP 6 -149.85 55.42 8 A TYR 10 58.52 142.34 8 A LEU 37 -49.08 -11.81 8 A LEU 41 -103.86 -63.87 8 A THR 44 -138.09 -47.91 8 A PHE 54 -49.25 -12.45 8 A HIS 61 -94.71 36.82 8 A HIS 62 75.50 -64.11 9 A ASP 6 -171.67 53.42 9 A ASP 8 41.57 21.99 9 A ASN 9 -49.10 -97.76 9 A TYR 11 78.83 40.17 9 A GLU 18 -47.74 -14.91 9 A ALA 29 -92.52 43.52 9 A LEU 30 -172.65 -28.41 9 A LEU 40 -63.29 0.41 9 A LEU 41 -96.06 -67.78 9 A THR 44 -140.31 -55.87 9 A VAL 49 -60.16 -70.61 9 A HIS 61 -67.13 -148.25 10 A GLU 3 -56.08 178.40 10 A ASP 6 -172.33 67.87 10 A PHE 7 64.07 156.44 10 A ASN 9 -45.95 173.09 10 A TYR 10 52.69 109.88 10 A TYR 11 79.31 40.87 10 A ASP 23 -98.64 -60.14 10 A SER 27 -136.17 -53.55 10 A THR 43 -144.31 23.20 10 A THR 44 -132.44 -48.07 10 A VAL 49 -60.69 -72.06 10 A PHE 54 -49.31 -14.90 10 A HIS 62 -73.33 -80.80 10 A HIS 63 -98.96 42.35 11 A GLU 3 53.79 169.24 11 A ASP 6 -148.89 54.22 11 A ASN 9 -41.83 -88.99 11 A TYR 11 74.54 40.46 11 A ALA 29 -145.70 -4.82 11 A LEU 30 -137.07 -33.75 11 A ALA 33 -53.21 -74.56 11 A THR 43 -148.42 20.74 11 A THR 44 -132.20 -47.85 11 A VAL 49 -61.25 -71.16 11 A HIS 62 67.52 -66.86 11 A HIS 63 -98.06 42.60 12 A ASP 6 -160.70 57.48 12 A ASN 9 41.07 -100.21 12 A TYR 11 72.10 38.11 12 A LEU 30 -177.35 -27.03 12 A LEU 37 -57.76 -9.45 12 A THR 43 -46.02 -14.20 12 A ASN 46 -139.86 -45.23 12 A HIS 60 -142.90 38.58 12 A HIS 61 -68.60 -176.61 12 A HIS 62 -81.15 -74.46 12 A HIS 63 -94.38 41.16 13 A GLU 3 55.47 84.49 13 A PHE 7 -80.06 39.78 13 A ASP 8 -148.67 24.90 13 A TYR 10 -71.70 38.48 13 A TYR 11 -168.43 40.93 13 A GLU 18 -59.20 -6.85 13 A LEU 30 -136.07 -31.50 13 A LEU 40 -68.75 0.57 13 A THR 43 -140.19 28.86 13 A THR 44 -135.20 -50.09 13 A VAL 49 -60.80 -72.16 13 A HIS 61 -82.48 34.37 13 A HIS 62 76.96 -63.45 13 A HIS 63 -76.57 42.58 14 A GLU 3 48.59 72.24 14 A ASP 6 -141.54 42.38 14 A ASN 9 -48.90 170.29 14 A TYR 10 58.59 142.11 14 A ALA 33 -54.89 -70.53 14 A THR 43 -149.94 18.63 14 A HIS 60 -95.56 -98.45 15 A GLU 3 -178.95 -179.76 15 A ASP 6 -144.08 48.70 15 A ASP 8 44.31 27.72 15 A ASN 9 -41.65 -77.11 15 A TYR 10 -41.92 154.54 15 A THR 43 -64.19 2.90 15 A HIS 60 -140.85 24.20 15 A HIS 62 81.89 -136.21 15 A HIS 63 -72.95 38.41 16 A GLU 3 70.35 129.64 16 A ASP 6 -156.77 59.15 16 A PHE 7 53.24 83.63 16 A ASP 8 -146.59 46.07 16 A ASN 9 41.51 -108.79 16 A LEU 41 -102.32 -62.85 16 A THR 44 -135.20 -48.64 16 A HIS 61 -71.75 -150.86 16 A HIS 62 -80.86 -80.86 16 A HIS 63 -97.74 43.50 17 A GLU 3 43.98 -168.87 17 A ASP 6 -144.51 41.60 17 A PHE 7 -59.78 105.42 17 A ASP 8 -146.14 -42.53 17 A ASN 9 49.45 -84.18 17 A TYR 10 -70.06 38.98 17 A TYR 11 -172.98 38.26 17 A ALA 29 -93.53 43.41 17 A LEU 30 -172.60 -28.14 17 A LEU 40 -64.07 0.44 17 A THR 44 -136.10 -52.36 17 A VAL 49 -60.91 -73.25 17 A HIS 60 -53.10 -83.25 17 A HIS 61 61.16 -71.68 18 A GLU 3 -178.63 -177.64 18 A ASP 6 -151.19 57.16 18 A PHE 7 -48.20 176.47 18 A ASP 8 -63.34 0.99 18 A TYR 10 -63.23 70.45 18 A ALA 13 -137.59 -35.44 18 A ALA 29 -93.70 43.00 18 A LEU 30 -172.32 -28.46 18 A THR 43 -152.55 26.73 18 A VAL 49 -60.35 -71.84 18 A HIS 60 -66.88 -123.67 19 A GLU 3 -172.57 93.52 19 A PHE 7 -73.84 47.33 19 A ASN 9 -52.78 171.09 19 A TYR 10 52.80 109.04 19 A TYR 11 79.74 40.94 19 A LEU 30 -137.56 -30.78 19 A LEU 37 -55.49 -5.80 19 A THR 44 -130.68 -48.63 19 A PHE 54 -49.30 -12.53 19 A HIS 61 -64.83 -123.13 19 A HIS 62 -98.62 -72.87 20 A ASP 6 178.36 61.71 20 A ASN 9 37.94 -122.55 20 A TYR 10 -38.82 125.57 20 A TYR 11 79.19 37.88 20 A LEU 30 -153.85 -36.71 20 A ALA 33 -62.93 -70.31 20 A LEU 40 -63.20 0.99 20 A LEU 41 -95.33 -74.01 20 A THR 44 -129.44 -50.10 20 A HIS 60 -67.20 -108.81 20 A HIS 61 -162.33 -90.64 20 A HIS 62 -140.71 -31.13 21 A GLU 3 -57.81 171.62 21 A ASP 6 -156.84 60.15 21 A ASP 8 -155.97 32.90 21 A ASN 9 -52.64 -80.38 21 A GLU 18 -56.64 -5.30 21 A ASP 23 -137.15 -35.52 21 A ALA 29 -93.16 31.82 21 A LEU 30 -168.96 -34.45 21 A LEU 40 -65.54 0.96 21 A LEU 41 -98.32 -60.74 21 A THR 44 -136.32 -51.60 21 A HIS 60 -79.52 35.20 21 A HIS 61 -56.12 -110.57 21 A HIS 62 -102.31 -69.52 22 A GLU 3 62.09 -171.46 22 A ASP 6 -177.81 67.95 22 A PHE 7 -51.33 170.34 22 A ASN 9 41.36 -93.19 22 A TYR 10 -41.89 154.93 22 A ALA 29 -93.59 42.29 22 A LEU 30 -171.14 -28.72 22 A THR 43 -146.96 11.80 22 A ASN 46 -135.87 -44.62 22 A HIS 60 -101.95 -70.06 22 A HIS 61 78.37 -144.33 22 A HIS 62 -60.57 -99.55 22 A HIS 63 -73.00 40.41 23 A GLU 2 42.42 -164.68 23 A GLU 3 60.53 161.56 23 A ASP 6 -163.65 43.85 23 A ASN 9 -41.54 -77.99 23 A TYR 10 -43.04 155.58 23 A GLU 18 -41.38 -73.85 23 A ALA 29 -93.44 43.30 23 A LEU 30 -173.14 -28.42 23 A LEU 41 -101.64 -61.99 23 A THR 44 -136.52 -46.91 23 A VAL 49 -59.93 -72.42 23 A HIS 61 -98.83 -82.92 24 A GLU 3 -172.88 145.63 24 A ASP 6 -148.20 42.28 24 A PHE 7 -151.24 74.36 24 A ASP 8 41.52 22.03 24 A ASN 9 -58.89 172.23 24 A TYR 11 -174.35 39.87 24 A SER 27 -94.34 31.19 24 A LEU 30 -143.97 -36.49 24 A LEU 40 -62.87 0.03 24 A LEU 41 -94.25 -69.18 24 A THR 44 -137.33 -51.72 24 A VAL 49 -58.97 -70.44 24 A HIS 60 -69.50 -118.50 24 A HIS 61 -160.30 -31.60 24 A HIS 62 -170.24 141.98 25 A GLU 3 -48.08 151.87 25 A ASP 8 -146.02 14.50 25 A TYR 10 58.67 140.43 25 A ALA 29 -92.39 41.46 25 A LEU 30 -172.26 -28.32 25 A THR 44 -133.18 -48.74 25 A VAL 49 -61.39 -70.95 25 A HIS 62 55.41 -82.57 25 A HIS 63 -88.14 41.03 26 A GLU 2 53.09 -177.16 26 A GLU 3 -172.76 45.32 26 A ASP 6 -151.01 58.08 26 A PHE 7 -73.89 -162.82 26 A TYR 10 -70.96 39.73 26 A TYR 11 -164.46 41.07 26 A GLU 18 -46.30 -72.76 26 A SER 27 -96.44 32.82 26 A LEU 30 -153.40 -35.77 26 A THR 43 -158.26 19.73 26 A HIS 60 -84.15 -98.42 26 A HIS 61 56.32 -78.71 27 A GLU 3 -173.10 99.21 27 A ASP 8 -155.36 52.96 27 A ASN 9 49.41 178.06 27 A TYR 10 -47.16 90.02 27 A SER 27 -92.66 30.38 27 A LEU 30 -147.21 -36.53 27 A VAL 49 -59.70 -71.29 27 A HIS 61 -89.87 39.91 27 A HIS 62 69.69 130.21 28 A GLU 3 -61.48 73.38 28 A ASP 6 -156.02 56.40 28 A ASN 9 -56.12 -169.74 28 A TYR 10 52.02 105.84 28 A SER 17 -122.49 -52.37 28 A SER 27 -102.92 48.52 28 A LEU 30 -172.99 -29.38 28 A THR 43 -47.79 -12.33 28 A ASN 46 -139.86 -46.27 28 A HIS 60 -96.93 59.09 28 A HIS 62 66.55 105.27 29 A GLU 2 -175.75 67.15 29 A ASP 8 -159.67 -47.54 29 A ASN 9 33.56 -89.38 29 A GLU 18 -41.61 -71.55 29 A ALA 29 -92.72 41.98 29 A LEU 30 -174.11 -28.20 29 A THR 44 -131.84 -42.49 29 A ASN 46 -123.37 -54.59 29 A VAL 49 -59.20 -71.03 29 A HIS 60 -89.80 -116.95 29 A HIS 61 -154.88 -66.29 29 A HIS 62 -162.76 -59.69 29 A HIS 63 -101.82 42.06 30 A GLU 3 -57.52 171.78 30 A ASP 6 -160.35 54.57 30 A PHE 7 59.78 112.45 30 A ASN 9 42.53 -158.55 30 A TYR 10 48.33 -152.96 30 A TYR 11 -59.44 74.52 30 A SER 17 -91.55 -60.13 30 A LEU 30 -174.50 -28.99 30 A ALA 33 -44.61 -71.66 30 A LEU 37 -46.94 -14.57 30 A THR 44 -131.16 -48.36 30 A VAL 49 -60.78 -70.93 30 A HIS 62 -97.28 -60.92 30 A HIS 63 -101.03 41.62 31 A ASP 6 -162.72 55.37 31 A PHE 7 -85.18 44.00 31 A ASP 8 -101.27 43.19 31 A ASN 9 -51.06 175.25 31 A TYR 10 58.46 128.64 31 A LEU 40 -65.38 1.85 31 A LEU 41 -99.46 -65.93 31 A THR 44 -135.07 -50.19 31 A HIS 62 55.19 -83.12 31 A HIS 63 -88.06 41.11 32 A GLU 2 46.90 -164.96 32 A ASP 6 -141.48 43.63 32 A PHE 7 54.12 167.25 32 A ASN 9 45.73 -172.87 32 A TYR 10 41.76 94.45 32 A TYR 11 78.64 41.97 32 A GLU 18 -48.91 -12.74 32 A ALA 29 59.57 16.06 32 A ALA 33 -55.60 -71.07 32 A LEU 40 -69.14 1.02 32 A ASN 46 -133.82 -62.52 32 A HIS 62 -174.06 -102.61 32 A HIS 63 -100.82 43.49 33 A GLU 2 54.88 -173.38 33 A ASP 6 -151.82 45.86 33 A PHE 7 -41.17 95.64 33 A ASN 9 52.53 167.83 33 A TYR 10 37.47 31.37 33 A TYR 11 -174.32 39.54 33 A TRP 24 -37.98 -33.73 33 A SER 27 -108.84 48.91 33 A LEU 30 -168.03 -28.80 33 A ASN 46 -123.72 -59.47 33 A VAL 49 -60.96 -70.41 33 A HIS 62 58.37 127.49 34 A GLU 2 41.79 -162.57 34 A ASP 6 -159.95 60.29 34 A PHE 7 47.41 -167.20 34 A ASN 9 41.34 -94.56 34 A LEU 30 -144.42 -36.00 34 A ASN 46 -135.26 -43.54 34 A VAL 49 -60.67 -71.63 34 A HIS 59 -165.06 22.11 34 A HIS 60 40.21 26.94 34 A HIS 61 -102.89 -135.57 34 A HIS 62 -100.94 -79.90 34 A HIS 63 -100.47 43.66 35 A GLU 3 -172.57 56.79 35 A PHE 7 -159.50 87.09 35 A ASP 8 -150.81 14.62 35 A ASN 9 -59.67 -92.55 35 A GLU 18 -46.72 -18.65 35 A ASP 23 -125.85 -56.15 35 A SER 27 -96.55 31.08 35 A LEU 30 -153.07 -36.33 35 A THR 43 -51.96 -6.71 35 A ASN 46 -153.78 -52.96 35 A HIS 61 -145.41 -157.98 35 A HIS 62 -93.45 -66.06 35 A HIS 63 -97.51 41.40 36 A GLU 3 63.31 151.52 36 A ASP 6 174.19 72.94 36 A ASP 8 42.95 22.81 36 A TYR 10 -71.15 40.50 36 A TYR 11 -169.64 38.26 36 A GLU 18 -56.58 -5.81 36 A ALA 29 -144.70 -2.40 36 A LEU 30 -139.15 -34.71 36 A THR 44 -140.31 -59.96 36 A HIS 62 -167.58 -65.83 36 A HIS 63 -101.12 42.73 37 A GLU 2 46.78 80.01 37 A ASP 6 -173.08 66.93 37 A ASP 8 -158.70 19.70 37 A TYR 10 -71.10 39.87 37 A TYR 11 -168.97 40.51 37 A HIS 61 -62.79 -80.43 37 A HIS 62 -142.46 -82.20 37 A HIS 63 -86.96 40.25 38 A GLU 3 53.44 -172.20 38 A ASN 9 -57.82 -170.16 38 A TYR 10 44.09 97.16 38 A TYR 11 71.61 39.30 38 A LEU 30 -158.46 17.78 38 A LEU 41 -131.27 -37.57 38 A THR 44 -136.96 -52.43 38 A HIS 60 -77.34 40.20 38 A HIS 62 -154.60 -65.75 38 A HIS 63 -100.70 42.04 39 A GLU 2 -101.01 79.20 39 A GLU 3 -57.58 -179.62 39 A ASP 6 -159.15 50.16 39 A PHE 7 -52.85 101.30 39 A ASN 9 42.19 -129.75 39 A ALA 13 -136.73 -34.76 39 A ALA 29 -93.91 43.47 39 A LEU 30 -172.82 -28.10 39 A LEU 40 -64.59 1.10 39 A LEU 41 -99.40 -66.36 39 A THR 44 -134.80 -51.05 39 A ASN 46 -102.47 -61.39 39 A HIS 59 -168.65 20.42 39 A HIS 62 -66.39 -78.87 39 A HIS 63 -92.30 39.26 40 A GLU 2 -165.23 71.81 40 A GLU 3 -173.06 42.71 40 A ASP 6 -150.70 46.55 40 A ASP 8 -152.86 40.59 40 A ASN 9 -43.58 168.44 40 A TYR 10 58.46 143.31 40 A SER 17 -136.89 -48.46 40 A ALA 29 -103.03 41.71 40 A LEU 30 -159.45 -32.92 40 A ASN 46 -134.29 -50.64 40 A PHE 54 -48.88 -13.26 40 A HIS 61 -99.40 55.70 40 A HIS 62 59.62 117.48 Extended conformation, model 10 Solution structure of AR55 in 50% HFIP 1 N N A GLU 20 A GLU 20 HELX_P A GLY 28 A GLY 28 1 1 9 A LEU 30 A LEU 30 HELX_P A THR 43 A THR 43 1 2 14 A GLY 45 A GLY 45 HELX_P A LYS 57 A LYS 57 1 3 13 MEMBRANE PROTEIN MEMBRANE PROTEIN APJ_HUMAN UNP 1 1 P35414 MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFR 1 55 2LOW 1 55 P35414 A 1 1 55 1 expression tag LYS 56 2LOW A P35414 UNP 56 1 expression tag LYS 57 2LOW A P35414 UNP 57 1 expression tag GLY 58 2LOW A P35414 UNP 58 1 expression tag HIS 59 2LOW A P35414 UNP 59 1 expression tag HIS 60 2LOW A P35414 UNP 60 1 expression tag HIS 61 2LOW A P35414 UNP 61 1 expression tag HIS 62 2LOW A P35414 UNP 62 1 expression tag HIS 63 2LOW A P35414 UNP 63 1 expression tag HIS 64 2LOW A P35414 UNP 64